Comparison of Therapeutic Effects of Alprazolam and Cinnarizine in Patients with Idiopathic Tinnitus: A Clinical Trial Study

Message:
Abstract:

Background and

Purpose

Several studies have mentioned the prevalence of chronic tinnitus in the communities and its adverse effects on the patients’ quality of life. Although no cure for this condition has been found, the use of drugs, benzodiazepines and antihistamines, is common among the current treatments. This study compared the effects of alprazolam and cinnarizine therapy in patients with idiopathic tinnitus.

Materials And Methods

This clinical trial study was done on 101 patients with idiopathic tinnitus. Patients were randomly divided into two groups and 15 days were treated with alprazolam and cinnarizine. The study data were analyzed using the SPSS software at the significant level of less than 0.05.

Results

Mean age of patients was 45.50 ± 12.40 years, ranged from 20 to 75 years. 67.3% (68) of patients were women and 32.7% (33) were men. The cure rate after treatment was 0% in alprazolam and 2.3% in cinnarizine groups, respectively. The rates of partial remission and drowsiness in alprazolam and cinnarizine groups were 47.7% and 43.2%, and 68.4% and 31.6%, respectively.

Conclusion

Alprazolam and cinnarizine are equally effective in the treatment of idiopathic tinnitus. Nevertheless, as the side effect of drowsiness was more in the alprazolam, it is preferable in terms of cinnarizine.

Language:
Persian
Published:
Journal of Mazandaran University of Medical Sciences, Volume:23 Issue: 106, 2013
Pages:
12 to 18
magiran.com/p1232506  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!